Guardant Health, Inc.
Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares
AI-generated summary
Director Tariq Musa filed to propose the sale of 116 common shares of Guardant Health Inc. with an aggregate market value of $19,242 through Charles Schwab & Co., Inc. on October 16, 2026. The shares were originally acquired through a restricted stock lapse on September 15, 2026. The proposed sale is associated with a trading plan adopted on December 17, 2025.
Key facts
- Seller
- Tariq Musa
- Relationship
- Director
- Shares to sell
- 116
- Market value
- $19,242.00
- Approximate sale date
- Oct 16, 2026
- Broker
- Charles Schwab & Co., Inc.
- Acquired
- Sep 15, 2026 · Restricted Stock Lapse
Rule 10b5-1 plan · adopted Dec 17, 2025
More GH filings
- 8-K
Filed Nov 3, 2026
- 4
Filed Oct 22, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.